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Abstract
Background: Diethyl phthalate (DEP) and di-n-butyl phthalate (DnBP) are industrial chemicals found in consumer
products that may increase risk of adverse health effects. Although use of personal care/beauty products is known
to contribute to phthalate exposure, no prior study has examined feminine hygiene products as a potential phthalate
source. In this study, we evaluate whether vaginal douching and other feminine hygiene products increase exposure
to phthalates among US reproductive-aged women.
Methods: We conducted a cross-sectional study on 739 women (aged 20–49) from the National Health and Nutrition
Examination Survey 2001–2004 to examine the association between self-reported use of feminine hygiene products
(tampons, sanitary napkins, vaginal douches, feminine spray, feminine powder, and feminine wipes/towelettes) with
urinary concentrations of monoethyl phthalate (MEP) and mono-n-butyl phthalate (MnBP), metabolites of DEP and
DnBP, respectively.
Results: A greater proportion of black women than white and Mexican American women reported use of vaginal
douches, feminine spray, feminine powder, and wipes/towelettes in the past month whereas white women were more
likely than other racial/ethnic groups to report use of tampons (p < 0.05). Douching in the past month was associated
with higher concentrations of MEP but not MnBP. No other feminine hygiene product was significantly associated with
either MEP or MnBP. We observed a dose–response relationship between douching frequency and MEP concentrations
(ptrend < 0.0001); frequent users (≥2 times/month) had 152.2 % (95 % confidence intervals (CI): (68.2 %, 278.3 %)) higher
MEP concentrations than non-users. We also examined whether vaginal douching mediates the relationship between
race/ethnicity and phthalates exposures. Black women had 48.4 % (95 % CI: 16.8 %, 88.6 %; p = 0.0002) higher MEP
levels than white women. Adjustment for douching attenuated this difference to 26.4 % (95 % CI:−0.9 %, 61.2 %;
p = 0.06). Mediation effects of douching were statistically significant for black-white differences (z = 3.71, p < 0.001)
but not for differences between Mexican Americans and whites (z = 1.80, p = 0.07).
Conclusions: Vaginal douching may increase exposure to DEP and contribute to racial/ethnic disparities in DEP
exposure. The presence of environmental chemicals in vaginal douches warrants further examination.
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Background
Phthalate acid esters, also known as phthalates, are a class
of multifunctional industrial chemicals that warrant public
health concern due to their ubiquitous presence in the en-
vironment and their potential effects on human health.
Low molecular weight phthalates such as diethyl phthalate
(DEP) and di-n-butyl phthalate (DnBP) are used in fra-
granced personal care products such as cologne/perfume,
hair products, deodorant, lotion, body wash, and nail
polish to retain scents [1, 2]. Because phthalates are not
chemically bound to products, product use can lead to
phthalates exposure through dermal absorption, inhal-
ation, and ingestion. Once in the body, phthalates are
quickly metabolized and excreted in urine, with elimin-
ation half-lives less than 24 h [3, 4]. Urinary metabolites of
DEP and DnBP are detected in 99 % of US women of
reproductive age [5].
Exposure to DnBP and DEP is associated with adverse
effects on reproductive, endocrine, and developmental
systems. Experimental animal studies find that DnBP,
but not DEP, has well-documented anti-androgenic ef-
fects on the reproductive systems of male offspring
exposed in utero [6]. The female reproductive system is
thought to be less sensitive to phthalate-induced disrup-
tion than the male reproductive system. However a recent
study that examined the effects of a phthalate mixture
(which included DnBP but not DEP) on female rat off-
spring exposed in utero reported reproductive malforma-
tions consistent with the Mayer–Rokitansky–Kuster–
Hauser syndrome [7]. Moreover, a recent study of DEP
toxicity found evidence of estrogenicity in both in vitro
and in vivo, in adult female rats, suggesting that DEP may
induce reproductive abnormalities in female reproductive
system by both genomic and non-genomic mode of ac-
tions [8]. The evidence of health effects in humans is still
evolving; however, epidemiologic studies suggest that
prenatal DnBP and DEP exposure is associated with sex
steroid hormone concentrations during pregnancy [9] and
may increase the risk of adverse health outcomes during
early childhood [10-12]. In adult women, DnBP exposure
is associated with increased risks of diabetes [13] and
endometriosis [14] while DEP exposure is associated with
increased biomarkers of oxidative stress [15], elevated
mammographic breast density and increased breast cancer
risk [16].
Phthalates exposure varies by race/ethnicity and socio-
economic status (SES). Black females and males have
higher levels of DEP metabolites than their white counter-
parts [17-20] and lower SES is associated with elevated
levels of DnBP [17, 21, 22] though reasons underlying
social disparities in phthalates exposures remain poorly
understood. Mounting evidence points to environmental
factors in shaping racial/ethnic and socioeconomic dis-
parities in reproductive health, so these disparities in
phthalates exposure may contribute to disparities in health
outcomes [23].
Given the concern over phthalate toxicity, it is import-
ant to identify modifiable sources of phthalates exposure
that may be targeted for exposure reduction strategies,
particularly for vulnerable populations. Personal care
product use is considered an important exposure pathway
for DEP and DnBP [24], particularly among reproductive-
aged women who use multiple products daily [25].
Numerous studies [10, 19, 25-27] report an association
between use of colognes/perfumes and other fragranced
products and higher urinary concentrations of mono-ethyl
phthalate (MEP), a metabolite of DEP, with MEP concen-
trations in fragrance users approximately 3 times that of
non-users [25]. Associations between personal care prod-
ucts and MnBP, the primary metabolite of DnBP, are less
consistent. Among the studies that examined these rela-
tionships, five found a positive association between some
type of personal care product use and urinary MnBP [10,
25, 27-29], three reported no association [25, 26, 28], and
one found an inverse association [19].
Feminine care products that are used vaginally, such
as douches, tampons, and deodorants, may be an unre
cognized exposure source of phthalates. In particular, va-
ginal douching, the practice of intravaginal cleansing
with a liquid solution, warrants consideration since most
commercial douches contain fragrance [30] and synthetic
fragrances are a mixture of compounds that often contain
phthalates [1, 31, 32]. The practice of vaginal douching
may also play a role in shaping chemical exposure dispar-
ities, since black women report douching more frequently
than white and Mexican American women [18, 19].
Although socio-cultural differences in personal care
product use have been hypothesized as a possible driver of
disparities in phthalates exposure [21], to our knowledge,
no study to date has characterized this relationship. We
conducted a cross-sectional study to examine the associ-
ation between self-reported use of vaginal douches and
other feminine hygiene products with DEP and DnBP me-
tabolites, MEP and MnBP respectively, among a nationally
representative sample of U.S. reproductive aged women.
We also examined whether differences in douching would




We pooled data from the 2001–2002 and 2003–2004
cycles of the National Health and Nutrition Examination
Survey (NHANES), a nationally representative survey and
physical examination of the civilian, non-institutionalized
U.S. population conducted by the US Centers for Disease
Control and Prevention (CDC). These cycles were the
only ones in which data were collected on use of feminine
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hygiene products. The sample was restricted to female
participants aged 20–49 who had self-reported data on
feminine hygiene product use (n = 2432). Of these, 805
participants had urinary measurements of MEP and
MnBP. We excluded participants who did not self-identify
as non-Hispanic white, non-Hispanic black, or Mexican
American (n = 66) resulting in a final sample size of 739
study participants.
Phthalate metabolite measurements
Phthalate metabolites were measured in approximately
one-third of NHANES participants. Concentration data for
MEP and MnBP were downloaded from the NHANES
website in September 2013. Spot urine samples were col-
lected in the Mobile Examination Center and stored at
−20 °C until shipped to CDC’s National Center for Envi-
ronmental Health for analysis. Analytical methods have
been described in detail elsewhere [33, 34]. Briefly, concen-
trations of phthalate metabolites were quantified using solid
phase extraction-high performance liquid chromatography-
isotope dilution-tandem mass spectrometry and expressed
as wet weights (ng/mL). Approximately 99 % of the urinary
phthalate metabolite data was above the limit of detection
(LOD); values below the LOD were substituted with LOD/
by the CDC [33, 34].
Feminine hygiene product use data. As part of the 2001–
2004 NHANES survey, reproductive-aged females were
asked the following question during a private face-to-face
interview, “During the past month, have you used any of
the following products for feminine hygiene: tampons,
sanitary napkins, vaginal douches, feminine spray, feminine
powder, feminine wipes/towelettes, or other feminine
hygiene products?” If the participant responded “yes”, she
was then asked about the use of each specific product.
From these questions, we created binary variables (yes/no)
for each type of product used (e.g. tampons, vaginal
douches, etc.)
Data on frequency of use was available for vaginal
douche use (but not any other feminine hygiene prod-
ucts). Douching frequency was assessed from the follow-
ing survey questions: “During the past 6 months, did you
douche? By douching we mean putting a substance into
your vagina either for routine cleansing or for vaginal irri-
tation or signs of infection?” If participants responded yes,
they were then asked, “During the past 6 months, how
often did you douche?” We used this data to classify par-
ticipants into one of three categories indicating intensity
of use: no use, occasional use (douche ≤ once per month),
or frequent use (douche ≥2 times per month).
Statistical analysis
Analyses were conducted in STATA v13.1. Because we
combined two survey cycles, we calculated new sample
weights for each participant equal to one half of the two-
year sample weights provided in the NHANES laboratory
files. All analyses were adjusted for the non-random
sampling design and the sample population weights. A
(two-sided) P-value <0.05 was considered statistically
significant.
We tested our primary hypothesis using multivariate
linear regression models where the outcome was individ-
ual phthalate metabolites and the main exposure variable
was use of individual feminine hygiene products. We nat-
ural log-transformed phthalate metabolite and creatinine
data prior to regression analysis to account for their non-
normal distributions. From these regression models, we
estimated the percent changes in phthalate metabolite
concentrations by product use as (e(β) −1) * 100 with 95 %
confidence intervals (CIs) estimated as (e(β ± 1.99 * SE) −1)
where β and SE are the estimated regression coefficient
and standard error, respectively.
We first examined multivariate associations between
phthalate metabolite concentrations and feminine hygiene
product use adjusted only for urinary creatinine concen-
trations (to account for urinary dilution) [35]. We then
assessed associations accounting for the following covari-
ates and potential confounders: age (continuous); body
mass index (BMI; continuous); race/ethnicity (non-His-
panic white, non-Hispanic black, and Mexican American);
and educational attainment (less than high school diploma;
high school diploma or equivalent; or more than high
school diploma). We also conducted a sensitivity analysis
by further adjusting for household poverty-income ratio
(PIR; the ratio of household income to poverty threshold
adjusted to family size and inflation) among the 698 partic-
ipants with available data.
Lastly, we evaluated whether douche use partially medi-
ated the association between race/ethnicity and phthalate
exposure in two ways. We first qualitatively examined
whether the effect estimate of race/ethnicity on phthalate
metabolite concentrations changed by greater than ten
percent after controlling for douching frequency. We then
formally tested for mediation using the Arioan test for
mediation using methodological extensions to accommo-
date categorical mediators [36, 37].
Results
Phthalate metabolite concentrations, feminine hygiene
product use, and demographic characteristics varied by
race/ethnicity among US reproductive-aged women
(Table 1). Black women were more likely to be obese, and
Mexican American women had the lowest educational
attainment. Compared to other racial/ethnic groups, white
women self-reported significantly higher use of tampons,
whereas black women self-reported significantly higher
use of the following feminine hygiene products: vaginal
douche, feminine spray, feminine powder, wipes/towel-
ettes, and other products (p < 0.05). For example, 37 % of
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black women reported douching in the previous month
compared to 14 and 10 % of white and Mexican-
American women, respectively (Table 1). Similarly, black
women reported douching more frequently than other
women (p < 0.001). Twenty percent of black women
reported douching frequently compared to 7 and 3 % in
white and Mexican-American women, respectively. Black
women also had significantly higher geometric mean
concentrations (ng/mL) of MEP and MnBP when com-
pared to white or Mexican-American women (p <0.001).
Douching was associated with increased urinary MEP
concentrations (Table 2) in both unadjusted and adjusted
models. For example, in adjusted models, women that re-
ported douching in the past month had 51.6 % (95 % CI:
18.8 %, 93.6 %) higher concentrations of MEP than non-
users. We also observed evidence of a monotonic dose re-
sponse relationship between douching frequency and
MEP concentrations (p-trend <0.001). In adjusted models,
women who reported occasional douche use in the past
6 months had 33.6 % (95 % CI: −0.3 %, 79.2 %) higher
MEP concentrations than non-users, and those who re-
ported frequent douche use had 152.2 % (95 % CI: 68.2 %,
278.3 %) higher MEP concentrations than non-users.
There was evidence of a positive association between
douching and MnBP but it did not reach statistical signifi-
cance. There were no other significant associations be-
tween the other feminine hygiene products and either
MEP or MnBP although effect estimates were large for
feminine spray, feminine powder, and other products. As-
sociations did not substantially change when we adjusted
for household income (data not shown).
To further understand whether douching partially ex-
plains the relationship between race/ethnicity and phthal-
ate metabolite levels, we modeled two linear regression
models for MEP, with and without douching frequency as
a covariate (Table 3). In the covariate-adjusted model that
did not account for douching, black women had 48.4 %
higher concentrations of MEP (95 % CI: 16.8 %, 88.6 %),
and Mexican American women had 58.2 % higher MEP
concentrations (95 % CI: 24.7 %, 100.8 %) compared to
white women. After controlling for douching frequency,
the effect estimate for black women decreased to 26.4 %
(95 % CI: −0.9 %, 61.2 %), and was no longer statistically
significant, while the effect estimate for Mexican Ameri-
can women increased to 70.1 % (95 % CI: 34.1 %,
115.9 %). Mediation effects of douching were statistically
significant for black-white differences (z = 3.71, p < 0.001)
but not statistically significant for differences between
Mexican Americans and whites (z = 1.80, p = 0.07).
Discussion
In this cross-sectional study of US reproductive aged-
women, we found that vaginal douching may be an im-
portant source of DEP exposure among US reproductive
aged women. In adjusted models, women who reported
douching in the past month had 52 % higher urinary
MEP concentrations than non-users. In addition, there
was evidence of a monotonic dose–response relationship
such that women who reported an average douching fre-
quency of two or more times a month had urinary MEP
concentrations that were 152 % higher than nonusers.
Table 1 Demographic characteristics, product use, and
phthalate metabolite concentrations by race/ethnicity among






American (N = 180)
p-valuea
Age (years), %
20-29 29 34 42 0.05
30-39 33 32 32
40-49 38 34 26
BMI (kg/m2), %b <0.001
<25 44 24 26
25 – 30 27 25 33




< HS graduate 9 25 47
HS graduate 22 24 21
> HS graduate 69 52 31
Feminine hygiene product use in past monthc, %
Tampon 55 31 22 <0.001
Sanitary Napkin 59 66 63 0.13
Vaginal Douche 14 37 10 <0.001
Feminine Spray 3 16 2 <0.001
Feminine Powder 2 12 2 <0.001
Wipes/Towelettes 7 16 13 0.004
Other Products 3 11 5 0.03
Average douching frequency in past 6 months, % <0.001



















18.2 (1.0) 32.3 (2.0) 23.7 (2.3) <0.001
aGroup differences evaluated by ANOVA for natural log transformed phthalate
metabolite concentrations and chi square test for categorical variables
bData missing for BMI (n =8)
cSome participants used multiple products
dGM, Geometric mean; GSE, Geometric standard error
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We found no associations between MEP and the other
feminine hygiene products. There are many possible rea-
sons for the lack of associations found. For example,
scented products used intravaginally may result in greater
chemical exposures than scented feminine hygiene prod-
ucts designed for external use. Alternatively, it is possible
that, despite the large point estimates (see Table 2), the
wide confidence intervals for the other feminine hygiene
products could reflect the larger variety of scented and
unscented products in these different categories relative to
those available for douching; unfortunately, specific brand
information and detail about scent was not collected in
NHANES.
We found no association between douching, or any
other product use, and urinary MnBP concentrations.
This is consistent with most epidemiologic studies that
Table 2 Associations of product use and phthalate metabolite concentrations (ng/mL) among US reproductive-aged women,
NHANES 2001-2004a
MEP MnBP
Unadjusted (N = 739) Adjusted (N = 731) Unadjusted (N = 739) Adjusted (N = 731)
% change 95 % CI % change 95 % CI % change 95 % CI % change 95 % CI
Feminine hygiene product use in past month
Tamponb −6.4 (−24.9, 16.6) 6.1 (−16.0, 35.5) 2.4 (−11.8, 18.9) 4.1 (−11.0, 21.9)
Sanitary napkinb −7.6 (−21.5, 8.7) −9.0 (−22.8, 7.2) −3.2 (−17.6, 13.6) −4.4 (−18.9, 12.7)
Vaginal doucheb 59.5* (22.7, 107.2) 51.6* (18.8, 93.6) 12.2 (−8.3, 37.3) 9.8 (−9.7, 33.6)
Feminine sprayb 79.7 (−2.6, 231.4) 63.2 (−12.4, 204.2) 26.4 (−15.0, 88.1) 20.7 (−21.0, 84.3)
Feminine powderb 64.9 (−16.4, 225.3) 49.4 (−23.9, 193.2) 23.7 (−25.7, 105.9) 16.6 (−32.1, 100.3)
Wipes/ Towelettesb 21.5 (−11.1, 65.9) 14.7 (−16.0, 56.7) −6.5 (−25.8, 17.9) −7.8 (−27.9, 17.9)
Other productsb 35.4 (−12.2, 108.7) 26.9 (−19.8, 100.8) 27.8 (−7.5, 76.7) 25.9 (−7.9, 72.1)
Average douching frequency in past 6 monthsb
Occasional (≤1 month) 40.5* (6.1, 86.1) 33.6 (−0.3,79.2) 7.7 (−5.6, 22.8) 8.2 (−4.5, 22.6)
Frequent (≥2 month) 154.4** (68.7, 283.6) 152.2** (68.2, 278.3) 29.0 (−6.2, 77.3) 24.1 (−10.3, 71.8)
P-trend <0.001 <0.001 0.094 0.145
aMEP and MnBP concentrations were natural log transformed. All models were adjusted for urinary creatinine; adjusted models additionally controlled for age,
race/ethnicity, BMI, and educational attainment
bReference group is non-users; *p < 0.05; ** p < 0.001
Table 3 Association between race/ethnicity and MEP (ng/mL) among US reproductive-aged women with and without adjustment
for douching frequency, NHANES 2001-2004
Model 1 (N = 731) Model 2 (N = 731)
% change 95 % CI % change 95 % CI
Race/Ethnicitya
Black 48.4* (16.8, 88.6) 26.4 (−0.9, 61.2)
Mexican-American 58.2** (24.7, 100.8) 70.1* (34.1, 115.9)
Age −0.1 (−1.2, 1.0) −0.4 (−1.5, 0.7)
Educational attainmentb
< HS graduate 19.0 (−20.2, 77.5) 6.6 (−26.7, 54.9)
HS graduate 30.7* (3.4, 65.1) 27.7* (2.3, 59.3)
BMI 0.3 (−0.9, 1.5) 0.2 (−1.0, 1.4)
Urinary creatinine 129.4** (92.3, 173.8) 124.5** (88.2, 167.9)
Douching frequency in past six monthsc
Occasional (≤1 month) - - 33.6 (−0.3, 79.2)
Frequent (≥2 month) - - 152.2** (68.2, 278.3)
R2 0.24 0.27
aReference group is white women
bReference group is > HS graduate
cReference group is non douche users; *p < 0.05; ** p < 0.001
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report stronger associations between fragranced personal
care products and MEP than MnBP. This may in part be
explained by the fact that, on average, higher concentra-
tions of DEP than DnBP are present in personal care
products [1, 2].
We observed racial/ethnic differences in phthalate expo-
sures as well as feminine hygiene practices consistent with
prior studies [21, 26]. Compared to white and Mexican
American women, we found that black women had higher
phthalate metabolite levels and were more likely to report
use of several feminine hygiene products including
douches, sprays, and powders. When we controlled for
frequency of douching, differences in urinary MEP con-
centrations between black and white women were attenu-
ated and no longer statistically significant, suggesting that
use of personal care products, such as vaginal douches,
may contribute to racial/ethnic disparities in phthalates
exposures. In contrast, Mexican American women had
higher MEP concentrations than white women, but these
differences were not explained by douching, indicating the
importance of other exposure sources among Mexican
Americans.
The reasons underlying racial/ethnic differences in
douching behavior are complex and likely involve individ-
ual as well as community-level drivers. Among African
American and white women, common motivations for
douching include: to feel fresh and clean, to remove men-
strual blood, to remove vaginal odors, after sexual activity,
and in response to vaginal discharge or irritation [30, 38].
Ferranti hypothesizes that structural forces, such as histor-
ical odor discrimination against African Americans and
targeted advertising of these products to African Ameri-
cans, have helped to establish the practice of douching as
a beauty norm specifically among the African American
community, and that norm is now perpetuated through
cultural and familial traditions [39]. Thus, environmental
justice advocates and practitioners may view the dispro-
portionate chemical exposures from douching as an “en-
vironmental injustice of beauty”, a framework that could
also be applied to other beauty practices used predomin-
ately by women of color such as hair straightening and
skin whitening.
Vaginal douching is associated with multiple adverse
health outcomes including increased risks of bacterial
vaginosis [40], pelvic inflammatory disease [41], and
possibly cervical cancer [42], and consequently this prac-
tice has been discouraged by the American College of
Obstetrics and Gynecology [43,44]. While these guidance
documents do not discuss potential chemical hazards and
their consequent health impacts on reproductive health,
recognition of this and other types of environmental risk
factors is growing among health care providers, and was
recently addressed in an ACOG Committee Opinion enti-
tled “Exposure to Toxic Environmental Agents” [45].
As our study did not make any direct connection to ad-
verse health consequences, the human health implications
of our findings warrant further research. While experi-
mental animal studies suggest that DEP is not a male
reproductive toxicant [46], several epidemiologic studies
have reported associations between maternal concentra-
tions of MEP during pregnancy and adverse reproductive
and developmental outcomes in their offspring, particu-
larly males [10, 11, 47]. A recent epidemiologic study of
adolescent girls found suggestive associations between
both in utero and peripubertal MEP concentrations and
earlier pubertal onset [48]. The disparity between the re-
sults in rodent and human studies has not been explained,
but may reflect differences in exposure route (oral admin-
istration in animals versus dermal or inhalation exposure
in humans), or may be due to other biological differences
between rodents and humans [25]. Moreover, localized
effects of DEP (or other phthalates) on the vaginal epithe-
lium or the vaginal microbiome have not been fully
considered in prior toxicological or epidemiologic studies.
Given the high levels of MEP and the widespread expos-
ure in US reproductive-aged women, its effect on vaginal
health warrant further consideration.
Our current study focused solely on phthalates expos-
ure; however, the vaginal route of exposure may also be
important for other chemicals found in these products.
Fragrance is typically a mixture of chemicals [49]. DEP
was a common component of fragrance, but a recent
study suggests that DEP exposure is declining in the US
population [50] and thus manufacturers may be replacing
it with other chemicals. In addition, preservatives such as
parabens and antimicrobial agents such as triclosan, which
have also been shown to have endocrine-disrupting prop-
erties, may be present in intravaginal products [51]. Fur-
ther research is needed to understand the effects of
chemical exposures on reproductive health since little is
known about the absorption and metabolism of environ-
mental chemicals that are vaginally administered. A small
pharmaceutical study found that serum estradiol concen-
trations were ten times higher when the same dose was
delivered via vaginal administration compared to oral ad-
ministration [52]. The differential uptake observed for
synthetic hormones may also apply to industrial chemicals
since many of them are suspected endocrine disrupters.
Further work should also examine how variations in vagi-
nal microbiota may change metabolism and absorption of
environmental chemicals since douching can alter the
chemical and biological environment of the vagina [53].
The cross-sectional nature of the study precludes the
ability to make any causal inferences about the direction
of the association between urinary MEP concentration
and douching. Additionally, there may be residual con-
founding from unaccounted phthalate sources. Higher
MEP levels have been associated with use of multiple
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personal care products such as perfumes/colognes, cos-
metics, and hair care products [19, 25, 27]. Data on
these potential sources of exposures were not available
in NHANES. It is possible that women who frequently
douche are also more likely to use other scented
personal care products. Among our study population,
women who douched reported using more feminine
hygiene products than those who did not douche (data
not shown). However, the observed dose–response rela-
tionship coupled with the null associations with the
other feminine hygiene products supports a plausible re-
lationship that warrants investigation in future studies.
Another limitation of this study is that we did not have
information on the chemical ingredients of the douches
used by study participants. For example, homemade
douching solutions comprised of vinegar and water
would be less likely to have phthalates than commer-
cially manufactured products; however, prior studies
suggest that majority of women use commercially manu-
factured douching products [30, 38]. Lastly, there may
be exposure misclassification since we only had access
to single, spot urine measurements and phthalates have
a short half-life in the human body [3,4]. Previous stud-
ies have shown that women’s exposures to MEP and
MnBP are relatively stable, with greater variability be-
tween individuals than within individuals [54]. However,
use of feminine hygiene products is likely episodic, vary-
ing across the menstrual cycle. Unfortunately, NHANES
only measures whether a product was or was not used
in the last month, so we were not able to determine time
since product use (or frequency of use) very precisely.
This measurement error is likely nondifferential and
would bias our results towards the null. Given the poten-
tial for nondifferential misclassification, the robust finding
between vaginal douching and MEP levels is quite
remarkable.
Our study also has several notable strengths. To our
knowledge, this study is one of the few, if not only, to
examine the association between self-reported use of fem-
inine hygiene products and urinary biomarkers of chemical
exposure. Our study population was large and included ra-
cial/ethnic, geographic, and socioeconomic diversity since
it was derived from a nationally representative sample. This
is also one of the first studies to identify potential mediat-
ing factors of racial/ethnic disparities in phthalates expo-
sures using appropriate statistical techniques.
Conclusions
Results of our study suggest that vaginal douching may be
a source of human exposure to DEP among frequent users
and contribute to racial/ethnic disparities in DEP expos-
ure. This study adds weight to existing recommendations
from health professionals that discourage the practice of
douching. Future studies should confirm these findings in
contemporary populations with more precise data and in-
clude assessment of other endocrine-disrupting chemicals
that may be used in vaginal douches. Additionally, further
research is needed on the adverse reproductive health
consequences of chemical exposures originating from
feminine hygiene products that are used in and around
the vaginal area.
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